FDA Expands Early Alert Program for High-Risk Device Issues
The initiative provides faster notifications on potentially high-risk removals or corrections for all medical devices.
The initiative provides faster notifications on potentially high-risk removals or corrections for all medical devices.
The U.S. EPA is alerting residents who reside near certain commercial sterilizing plants of the health risks EtO emissions can cause.
The FDA is aware that the current reprocessing instructions for certain urological endoscopes manufactured by Karl Storz are being updated.
The initiative provides faster notifications on potentially high-risk removals or corrections for all medical devices.
The plan seeks to strengthen regulatory science and identify current and emerging issues in medical device research and regulation for women’s health.
Read MoreThe FDA’s new medical device inspections dashboard indicates that there are county level hotspots for inspection rates, but not state or region hotspots.
Read MoreFDA raised awareness of a cybersecurity vulnerability in Apache’s Log4j software library, which is used in medical devices and supporting systems.
Read MoreMED Institute obtained FDA qualification of their new Medical Device Development Tool for virtual MRI safety evaluations.
Read MoreAn analysis of the U.S. FDA’s Manufacturer and User Facility Device Experience database has discovered that medical device-associated patient deaths are being mislabeled in the system—mistakes that could impede patient care.
Read MoreAs the Right to Repair movement gains momentum, a Proto article asks, should hospitals be allowed to fix machines themselves?
Read MoreOlympus announces that it supports the updated safety recommendations from the U.S. FDA for bronchoscope reprocessing and single-use bronchoscopes.